<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

</DIV>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<DIV STYLE="text-align: left; margin-top: 0pt; margin-bottom: 3pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of report (Date of earliest event reported):
December 27, 2013</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OMEGA HEALTHCARE INVESTORS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maryland</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>1-11316</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>38-3041398</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(State of incorporation)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>200 International Circle</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><B>Suite 3500</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Hunt Valley, Maryland 21030 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive offices / Zip
Code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(410) 427-1700</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><B>Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.7in"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.7in"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.7in"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>&nbsp;&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.7in"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>&nbsp;&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P></DIV></DIV>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<DIV STYLE="text-align: left; margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P></DIV></DIV>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="text-align: left; margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Item 1.01&nbsp;&nbsp;Entry into a Material Definitive
Agreement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On December 27, 2013, Omega
Healthcare Investors, Inc. (&ldquo;Omega&rdquo;) entered into a new $200 million senior unsecured, deferred draw, term loan facility
(the &ldquo;2013 Term Loan Facility&rdquo;). The 2013 Term Loan Facility matures on February&nbsp;29, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The 2013 Term Loan Facility
is being provided pursuant to a Credit Agreement, dated as of December 27, 2013 (the &ldquo;2013 Credit Agreement&rdquo;), among
Omega, as borrower, certain of Omega&rsquo;s subsidiaries identified in the 2013 Credit Agreement, as guarantors, Bank of America,
N.A., as the initial lender (together with other lenders from time to time becoming signatory to the 2013 Credit Agreement, as
lenders, the &ldquo;2013 Term Lenders&rdquo;), and Bank of America, N.A., as administrative agent for the 2013 Term Lenders. Omega&rsquo;s
obligations in connection with the 2013 Term Loan Facility are jointly and severally guaranteed by Omega&rsquo;s current subsidiaries
(other than those designated as &ldquo;unrestricted subsidiaries&rdquo;) for the benefit of the administrative agent and the 2013
Term Lenders. Additional subsidiaries created or acquired by Omega in the future (unless designated as unrestricted subsidiaries)
will also be required to guarantee Omega&rsquo;s obligations in connection with the 2013 Term Loan Facility, if such future subsidiaries
own unencumbered real property or guarantee other unsecured funded debt (including but not limited to Omega&rsquo;s unsecured senior
notes and Omega&rsquo;s 2012 senior unsecured revolving credit and term loan facilities).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">No borrowings have yet
been made by Omega under the 2013 Term Loan Facility. Proceeds of future such borrowings may be used only to finance general corporate
working capital (including repayment of existing indebtedness, asset acquisitions, acquiring or improving income producing healthcare
facilities, and investments incidental or related to such purposes), capital expenditures or other corporate purposes of Omega
and its subsidiaries that guarantee the 2013 Term Loan Facility. Omega currently anticipates drawing on the 2013 Term Loan Facility
early in 2014 to repay outstanding borrowings under Omega&rsquo;s 2012 senior unsecured revolving credit facility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">From time to time, certain
of the 2013 Term Lenders, their affiliates and/or their predecessors have provided commercial banking, investment banking and other
financial advisory services to Omega or served as underwriters or sales agents for offerings of Omega&rsquo;s equity or debt, for
which they have received customary fees. Such services have included affiliates of certain of the 2013 Term Lenders serving as
lenders under Omega&rsquo;s 2012 senior unsecured revolving credit and term loan facilities. Assuming Omega repays borrowings under
Omega&rsquo;s 2012 senior unsecured revolving credit facility with proceeds from borrowings under the 2013 Term Loan Facility,
such lenders would receive a portion of such proceeds. Affiliates of certain of the 2013 Term Lenders have served as sales agents
under Omega&rsquo;s at-the-market Equity Shelf Program. The 2013 Term Lenders and their affiliates may, from time to time in the
future, engage in transactions with and perform services for Omega in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The material terms of the
2013 Credit Agreement are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Term Loan Advances
and Repayment.</I> Subject to its satisfaction of customary drawing conditions, Omega has the right to draw under the 2013 Term
Loan Facility up to three times until February 28, 2014, or until such earlier date as the 2013 Term Loan Facility has been fully
advanced or is terminated (the &ldquo;Term Loan Commitment Period&rdquo;). Any undrawn portion of the term loan commitment will
terminate upon the expiration of the Term Loan Commitment Period and cease to be available. The principal amount advanced under
the 2013 Term Loan Facility does not amortize, and is due and payable in full on February 29, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P></DIV></DIV>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="text-align: left; margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Interest Rates
and Fees.</I> The interest rates per annum applicable to the 2013 Term Loan Facility are (a)&nbsp;the reserve adjusted LIBOR Rate
(the &ldquo;Eurodollar Rate&rdquo; or &ldquo;Eurodollar&rdquo;), plus the applicable margin (as described below) or, at our option,
(b)&nbsp;the base rate, plus the applicable margin (as described below), with the base rate being equal to the highest of (i)&nbsp;the
rate of interest publicly announced by the administrative agent as its prime rate in effect, (ii)&nbsp;the federal funds effective
rate from time to time plus 0.50% and (iii) the Eurodollar Rate determined on such day for a Eurodollar Loan with an interest period
of one month plus 1.0%, in each case<FONT STYLE="color: blue">. </FONT>The applicable margins with respect to the 2013 Term Loan
Facility are determined in accordance with a performance grid based on our investment grade ratings from Standard &amp; Poor&rsquo;s,
Moody&rsquo;s and/or Fitch Ratings with respect to Omega&rsquo;s non-credit-enhanced, senior unsecured long-term debt. The applicable
margin for the 2013 Term Loan Facility may range from 2.30% to 1.10% in the case of Eurodollar advances, and from 1.30% to 0.10%<FONT STYLE="color: blue">
</FONT>in the case of base rate advances. The default rate on the 2013 Term Loan Facility is 2.0% above the interest rate otherwise
applicable to base rate loans. We are also obligated to pay an unused fee on the undrawn portion of the 2013 Term Loan Facility
to the 2013 Term Lenders equal to 0.30% per annum on the unused portion of the 2013 Term Loan Facility during the Term Loan Commitment
Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Prepayments;
Reduction or Termination of Commitments. </I>We may prepay the 2013 Term Loan Facility at any time in whole or in part, or reduce
or terminate the term loan commitment under the 2013 Term Loan Facility, in each case without fees or penalty. Principal amounts
prepaid or repaid under the 2013 Term Loan Facility may not be reborrowed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Covenants.</I>
The 2013 Credit Agreement contains customary affirmative and negative covenants, including, without limitation, limitations on
indebtedness; limitations on investments; limitations on liens; limitations on mergers and consolidations; limitations on sales
of assets; limitations on transactions with affiliates; limitations on negative pledges; limitations on prepayment of debt; limitations
on use of proceeds; limitations on changes in lines of business; limitations on repurchases of Omega capital stock if a default
or event of default exists; and maintenance of real estate investment trust (&ldquo;REIT&rdquo;) status. In addition, the 2013
Credit Agreement contains financial covenants, including, without limitation, those relating to maximum total leverage, maximum
secured leverage, maximum unsecured leverage, minimum fixed charge coverage, minimum consolidated tangible net worth, minimum unsecured
debt yield, minimum unsecured interest coverage and maximum distributions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Events of Default.</I>
The 2013 Credit Agreement includes customary events of default including, without limitation, nonpayment of principal, interest,
fees or other amounts when due, material breach of representations and warranties, covenant defaults, cross-defaults, a change
of control, bankruptcy events, material unsatisfied or unstayed judgments and loss of REIT status.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P></DIV></DIV>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="text-align: left; margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Right to Increase
Maximum Borrowings. </I>Pursuant to the terms and subject to the conditions of the 2013 Credit Agreement, the 2013 Term Lenders
have agreed that Omega may add one or more incremental tranches of term loans to the 2013 Term Loan Facility in an aggregate principal
amount of all such incremental tranches of term loans not to exceed $200&nbsp;million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><I>Guarantees.</I>
Omega&rsquo;s current subsidiaries that are not unrestricted subsidiaries under the 2013 Credit Agreement (with the exception of
sixty three recently created or acquired subsidiaries which are required to become guarantors of the 2013 Term Loan Facility by
the earlier of February 28, 2014, and the date on which such subsidiaries guarantee any other unsecured funded debt) jointly and
severally guarantee Omega&rsquo;s obligations in connection with the 2013 Term Loan Facility on an unsecured basis. Additional
subsidiaries created or acquired by Omega in the future (unless designated as unrestricted subsidiaries) will also be required
similarly to guarantee Omega&rsquo;s obligations in connection with the 2013 Term Loan Facility, if such future subsidiaries own
unencumbered real property or guarantee other unsecured funded debt (including, but not limited to, Omega&rsquo;s unsecured senior
notes and Omega&rsquo;s 2012 senior unsecured revolving credit and term loan facilities).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The 2013 Credit Agreement
is attached to this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01&#9;Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD NOWRAP><U>Exhibit No.</U></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 100%"><U>Description of Exhibit</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>10.1</TD>
    <TD>&nbsp;</TD>
    <TD>Credit Agreement, dated as
of December 27, 2013, among Omega Healthcare Investors, Inc., certain subsidiaries of Omega Healthcare Investors, Inc. identified
therein as guarantors, the lenders named therein and Bank of America, N.A., as administrative agent for such lenders.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></DIV></DIV>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="text-align: left; margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><B>OMEGA HEALTHCARE INVESTORS, INC.</B><BR> (Registrant)</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="padding-bottom: 1pt">Dated: January 3, 2014</TD>
    <TD STYLE="padding-bottom: 1pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;/s/&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">C. Taylor Pickett</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>C. Taylor Pickett<BR>
President and Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</DIV></DIV>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="text-align: left; margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="text-align: left; margin-top: 12pt; margin-bottom: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P></DIV></DIV>




<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "t1400001_8-k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 26385}]
{"company-data": {"conformed-name": "OMEGA HEALTHCARE INVESTORS INC", "cik": "0000888491", "assigned-sic": "6798", "irs-number": "383041398", "state-of-incorporation": "MD", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-11316", "film-number": "14506698"}, "business-address": {"street1": "200 INTERNATIONAL CIRCLE", "street2": "SUITE 3500", "city": "HUNT VALLEY", "state": "MD", "zip": "21030", "phone": "410-427-1700"}, "mail-address": {"street1": "200 INTERNATIONAL CIRCLE", "street2": "SUITE 3500", "city": "HUNT VALLEY", "state": "MD", "zip": "21030"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
December 27, 2013
OMEGA HEALTHCARE INVESTORS, INC.
(Exact name of registrant as specified in charter)
Maryland
1-11316
38-3041398
(State of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
200 International Circle
Suite 3500
Hunt Valley, Maryland 21030
(Address of principal executive offices / Zip
Code)
(410) 427-1700
(Registrant's telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
£
Written
communications pursuant to Rule 425 under the Securities Act.
£
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act.
£
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act.
£
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act.
Item 1.01  Entry into a Material Definitive
Agreement.
On December 27, 2013, Omega
Healthcare Investors, Inc. ("Omega") entered into a new $200 million senior unsecured, deferred draw, term loan facility
(the "2013 Term Loan Facility"). The 2013 Term Loan Facility matures on February 29, 2016.
The 2013 Term Loan Facility
is being provided pursuant to a Credit Agreement, dated as of December 27, 2013 (the "2013 Credit Agreement"), among
Omega, as borrower, certain of Omega's subsidiaries identified in the 2013 Credit Agreement, as guarantors, Bank of America,
N.A., as the initial lender (together with other lenders from time to time becoming signatory to the 2013 Credit Agreement, as
lenders, the "2013 Term Lenders"), and Bank of America, N.A., as administrative agent for the 2013 Term Lenders. Omega's
obligations in connection with the 2013 Term Loan Facility are jointly and severally guaranteed by Omega's current subsidiaries
(other than those designated as "unrestricted subsidiaries") for the benefit of the administrative agent and the 2013
Term Lenders. Additional subsidiaries created or acquired by Omega in the future (unless designated as unrestricted subsidiaries)
will also be required to guarantee Omega's obligations in connection with the 2013 Term Loan Facility, if such future subsidiaries
own unencumbered real property or guarantee other unsecured funded debt (including but not limited to Omega's unsecured senior
notes and Omega's 2012 senior unsecured revolving credit and term loan facilities).
No borrowings have yet
been made by Omega under the 2013 Term Loan Facility. Proceeds of future such borrowings may be used only to finance general corporate
working capital (including repayment of existing indebtedness, asset acquisitions, acquiring or improving income producing healthcare
facilities, and investments incidental or related to such purposes), capital expenditures or other corporate purposes of Omega
and its subsidiaries that guarantee the 2013 Term Loan Facility. Omega currently anticipates drawing on the 2013 Term Loan Facility
early in 2014 to repay outstanding borrowings under Omega's 2012 senior unsecured revolving credit facility.
From time to time, certain
of the 2013 Term Lenders, their affiliates and/or their predecessors have provided commercial banking, investment banking and other
financial advisory services to Omega or served as underwriters or sales agents for offerings of Omega's equity or debt, for
which they have received customary fees. Such services have included affiliates of certain of the 2013 Term Lenders serving as
lenders under Omega's 2012 senior unsecured revolving credit and term loan facilities. Assuming Omega repays borrowings under
Omega's 2012 senior unsecured revolving credit facility with proceeds from borrowings under the 2013 Term Loan Facility,
such lenders would receive a portion of such proceeds. Affiliates of certain of the 2013 Term Lenders have served as sales agents
under Omega's at-the-market Equity Shelf Program. The 2013 Term Lenders and their affiliates may, from time to time in the
future, engage in transactions with and perform services for Omega in the ordinary course of business.
The material terms of the
2013 Credit Agreement are as follows:
Term Loan Advances
and Repayment.
Subject to its satisfaction of customary drawing conditions, Omega has the right to draw under the 2013 Term
Loan Facility up to three times until February 28, 2014, or until such earlier date as the 2013 Term Loan Facility has been fully
advanced or is terminated (the "Term Loan Commitment Period"). Any undrawn portion of the term loan commitment will
terminate upon the expiration of the Term Loan Commitment Period and cease to be available. The principal amount advanced under
the 2013 Term Loan Facility does not amortize, and is due and payable in full on February 29, 2016.
2
Interest Rates
and Fees.
The interest rates per annum applicable to the 2013 Term Loan Facility are (a) the reserve adjusted LIBOR Rate
(the "Eurodollar Rate" or "Eurodollar"), plus the applicable margin (as described below) or, at our option,
(b) the base rate, plus the applicable margin (as described below), with the base rate being equal to the highest of (i) the
rate of interest publicly announced by the administrative agent as its prime rate in effect, (ii) the federal funds effective
rate from time to time plus 0.50% and (iii) the Eurodollar Rate determined on such day for a Eurodollar Loan with an interest period
of one month plus 1.0%, in each case
.
The applicable margins with respect to the 2013 Term Loan
Facility are determined in accordance with a performance grid based on our investment grade ratings from Standard & Poor's,
Moody's and/or Fitch Ratings with respect to Omega's non-credit-enhanced, senior unsecured long-term debt. The applicable
margin for the 2013 Term Loan Facility may range from 2.30% to 1.10% in the case of Eurodollar advances, and from 1.30% to 0.10%
in the case of base rate advances. The default rate on the 2013 Term Loan Facility is 2.0% above the interest rate otherwise
applicable to base rate loans. We are also obligated to pay an unused fee on the undrawn portion of the 2013 Term Loan Facility
to the 2013 Term Lenders equal to 0.30% per annum on the unused portion of the 2013 Term Loan Facility during the Term Loan Commitment
Period.
Prepayments;
Reduction or Termination of Commitments.
We may prepay the 2013 Term Loan Facility at any time in whole or in part, or reduce
or terminate the term loan commitment under the 2013 Term Loan Facility, in each case without fees or penalty. Principal amounts
prepaid or repaid under the 2013 Term Loan Facility may not be reborrowed.
Covenants.
The 2013 Credit Agreement contains customary affirmative and negative covenants, including, without limitation, limitations on
indebtedness; limitations on investments; limitations on liens; limitations on mergers and consolidations; limitations on sales
of assets; limitations on transactions with affiliates; limitations on negative pledges; limitations on prepayment of debt; limitations
on use of proceeds; limitations on changes in lines of business; limitations on repurchases of Omega capital stock if a default
or event of default exists; and maintenance of real estate investment trust ("REIT") status. In addition, the 2013
Credit Agreement contains financial covenants, including, without limitation, those relating to maximum total leverage, maximum
secured leverage, maximum unsecured leverage, minimum fixed charge coverage, minimum consolidated tangible net worth, minimum unsecured
debt yield, minimum unsecured interest coverage and maximum distributions.
Events of Default.
The 2013 Credit Agreement includes customary events of default including, without limitation, nonpayment of principal, interest,
fees or other amounts when due, material breach of representations and warranties, covenant defaults, cross-defaults, a change
of control, bankruptcy events, material unsatisfied or unstayed judgments and loss of REIT status.
3
Right to Increase
Maximum Borrowings.
Pursuant to the terms and subject to the conditions of the 2013 Credit Agreement, the 2013 Term Lenders
have agreed that Omega may add one or more incremental tranches of term loans to the 2013 Term Loan Facility in an aggregate principal
amount of all such incremental tranches of term loans not to exceed $200 million.
Guarantees.
Omega's current subsidiaries that are not unrestricted subsidiaries under the 2013 Credit Agreement (with the exception of
sixty three recently created or acquired subsidiaries which are required to become guarantors of the 2013 Term Loan Facility by
the earlier of February 28, 2014, and the date on which such subsidiaries guarantee any other unsecured funded debt) jointly and
severally guarantee Omega's obligations in connection with the 2013 Term Loan Facility on an unsecured basis. Additional
subsidiaries created or acquired by Omega in the future (unless designated as unrestricted subsidiaries) will also be required
similarly to guarantee Omega's obligations in connection with the 2013 Term Loan Facility, if such future subsidiaries own
unencumbered real property or guarantee other unsecured funded debt (including, but not limited to, Omega's unsecured senior
notes and Omega's 2012 senior unsecured revolving credit and term loan facilities).
The 2013 Credit Agreement
is attached to this Current Report on Form 8-K as Exhibit 10.1 and is incorporated herein by reference.
Item 9.01	Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
Description of Exhibit
10.1
Credit Agreement, dated as
of December 27, 2013, among Omega Healthcare Investors, Inc., certain subsidiaries of Omega Healthcare Investors, Inc. identified
therein as guarantors, the lenders named therein and Bank of America, N.A., as administrative agent for such lenders.
4
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
OMEGA HEALTHCARE INVESTORS, INC.
(Registrant)
Dated: January 3, 2014
By:
/s/
C. Taylor Pickett
C. Taylor Pickett
President and Chief Executive Officer